SureTrader Advertisement SureTrader
Home > Boards > Free Zone > Health and Sciences > Biotech Values

VVUS—This might be a good time to review

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 618
Posts 92,379
Boards Moderated 28
Alias Born 09/05/02
160x600 placeholder
Stocks Trim Losses As Strong Services-sector Data Spark Some Risk Appetite
But private-payroll gains miss expectations; productivity falls U.S. stocks trimmed early losses Wednesday, after a gauge of activity in...
Top Equities Stories Of The Day
Correction to Fitbit Jawbone Article on April 29
Deutsche Bank North America CEO Jacques Brand to Leave for PJT Partners
Ackman: No Plans to Sell Any Valeant `Crown Jewel' Assets -CNBC
Brazilian Judge Lifts WhatsApp Ban -- Update
Auto Sales Spring Ahead -- WSJ
Oil Pares Gains on Big Rise in Inventories
Gilead Seeks to Tame Merck Case -- WSJ
Zillow Beats Expectations, Lifts Sales View
DewDiligence Member Level  Thursday, 02/23/12 11:29:54 AM
Re: biotech jim post# 137678
Post # of 201146 
VVUS—This might be a good time to review the table in #msg-59407483 :- )

Note that Contrave is one of the items on the list.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist